Correlation of Patient-Related Factors and Dose-Volume Histogram Parameters with the Onset of Radiation Pneumonitis in Patients with Small Cell Lung Cancer

被引:33
作者
Roeder, Falk [1 ,2 ]
Friedrich, Jochen [1 ]
Timke, Carmen [1 ,2 ]
Kappes, Jutta
Huber, Peter [1 ,2 ]
Krempien, Robert [3 ]
Debus, Juergen [1 ,2 ]
Bischof, Marc [1 ]
机构
[1] Univ Heidelberg, Dept Radiat Oncol, D-69120 Heidelberg, Germany
[2] DKFZ, Clin Cooperat Unit Radiat Oncol, Heidelberg, Germany
[3] Helios Ciln Berlin Buch, Dept Radiat Oncol, Berlin, Germany
关键词
Radiation pneumonitis; Small cell lung cancer; Dose-volume constraints; CONFORMAL RADIOTHERAPY; CONCURRENT CHEMOTHERAPY; THERAPY; TOXICITY; IRRADIATION; NSCLC; RISK; ESCALATION; PREDICTION; MODALITY;
D O I
10.1007/s00066-010-2018-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: To analyze the association of patient- and treatment-related factors with the onset of radiation pneumonitis in a homogeneously treated cohort of patients suffering from small cell Lung cancer (SCLC). Patients and Methods: 242 patients with SCLC staged as limited disease, who had been treated with chemotherapy and three-dimensional conformal radiotherapy, were retrospectively analyzed. Pneumonitis was defined by typical symptoms and radiographic findings and judged clinically relevant, if drug administration and hospitalization were necessary. Patient- (age, gender, smoking history, performance status, tumor Localization, benign lung disease) and treatment-related parameters (V(10)-V(40), mean lung dose [MLD]) were analyzed using chi(2)-tests for categorical parameters and Logistic regression for continuous variables. Results: 33 patients (13.6%) developed a clinically relevant pneumonitis, of whom three patients died. ALL cases of pneumonitis developed within 120 days. None of the patient-related parameters correlated significantly with the onset of pneumonitis. Considering treatment-related parameters, a significant correlation of V(30) in regard to total lung and V(40) in regard to ipsilateral, contralateral and total Lung to the risk of pneumonitis was found. So, the estimated risk of a clinically relevant pneumonitis increased from 10% given a V(30) of 13% to 30% given a V(30) of 35%. In contrast, no significant correlation was found for V(10) and V(20) and only a trend for MLD. Conclusion: In this series, high-dose radiation volume parameters, i.e., V(30) and especially V(40), were identified as the most important factors for the development of radiation pneumonitis. Low-dose radiation volume parameters and clinical parameters played an inferior role in predicting the pneumonitis risk.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 30 条
[1]
STRATEGY FOR DOSE-ESCALATION USING 3-DIMENSIONAL CONFORMAL RADIATION-THERAPY FOR LUNG-CANCER [J].
ARMSTRONG, JG ;
ZELEFSKY, MJ ;
LEIBEL, SA ;
BURNAM, C ;
HAN, C ;
HARRISON, LB ;
KUTCHER, GJ ;
FUKS, ZY .
ANNALS OF ONCOLOGY, 1995, 6 (07) :693-697
[2]
Bischof M, 2007, STRAHLENTHER ONKOL, V183, P679, DOI 10.1007/s00066-007-1740-z
[3]
Late effects of thoracic irradiation in children [J].
Boelling, Tobias ;
Koenemann, Stefan ;
Ernst, Iris ;
Willich, Normann .
STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (06) :289-295
[4]
Bölling T, 2008, STRAHLENTHER ONKOL, V184, P193, DOI 10.1007/s00066-008-1810-x
[5]
Radiation Toxicity Following Busulfan/Melphalan High-dose Chemotherapy in the EURO-EWING-99-trial: Review of GPOH Data [J].
Boelling, Tobias ;
Dirksen, Uta ;
Ranft, Andreas ;
Ernst, Iris ;
Juergens, Heribert ;
Willich, Normann .
STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 :21-22
[6]
Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung [J].
Byhardt, RW ;
Scott, C ;
Sause, WT ;
Emami, B ;
Komaki, R ;
Fisher, B ;
Lee, JS ;
Lawton, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (03) :469-478
[7]
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer:: clinical and dosimetric factors analysis [J].
Claude, L ;
Pérol, D ;
Ginestet, C ;
Falchero, L ;
Arpin, D ;
Vincent, M ;
Martel, I ;
Hominal, S ;
Cordier, JF ;
Carrie, C .
RADIOTHERAPY AND ONCOLOGY, 2004, 71 (02) :175-181
[8]
The relationship between local dose and loss of function for irradiated lung [J].
Gopal, R ;
Tucker, SL ;
Komaki, R ;
Liao, ZX ;
Forster, KM ;
Stevens, C ;
Kelly, JF ;
Starkschall, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01) :106-113
[9]
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [J].
Graham, MV ;
Purdy, JA ;
Emami, B ;
Harms, W ;
Bosch, W ;
Lockett, MA ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02) :323-329
[10]
Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer [J].
Hernando, ML ;
Marks, LB ;
Bentel, GC ;
Zhou, SM ;
Hollis, D ;
Das, SK ;
Fan, M ;
Munley, MT ;
Shafman, TD ;
Anscher, MS ;
Lind, PA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03) :650-659